日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy

利用深度学习分析肥厚型心肌病中的三维微结构重塑

Wei, Eric Q; Beyer, Martin; Brown, Kemar J; Bansbach, Alexander J; Gorham, Joshua M; McDonough, Barbara; Chen, Huachen; Khoramjoo, Mobin; Zhang, Anran; Bishop, Brian; Ahmad, Ferhaan; Del Rio, Carlos; Chang, Ching-Pin; Ryba, David M; Day, Sharlene M; Fatkin, Diane; Oudit, Gavin Y; Seidman, Christine E; Seidman, Jonathan G

Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Coramitug,一种用于治疗转甲状腺素蛋白淀粉样变性心肌病的人源化单克隆抗体:一项 II 期随机、多中心、双盲、安慰剂对照试验

Fontana, Marianna; García-Pavía, Pablo; Grogan, Martha; Shah, Sanjiv J; Engelmann, Mads D M; Hovingh, G Kees; Kristen, Arnt V; Lim-Watson, Michelle Z; Malling, Brian; Kar, Soumitra; Revanna, Manjunatha; Sarswat, Nitasha; Tsujita, Kenichi; Alexander, Kevin M; Maurer, Mathew S

Transthyretin amyloid cardiomyopathy: from cause to novel treatments

转甲状腺素蛋白淀粉样变性心肌病:从病因到新型疗法

Fontana, Marianna; Aimo, Alberto; Emdin, Michele; Porcari, Aldostefano; Solomon, Scott D; Hawkins, Philip N; Gillmore, Julian D

Cardiac Sodium Channel Regulation: A Potential New Therapeutic Target in Cardiomyopathy

心脏钠通道调控:心肌病潜在的新治疗靶点

Dudley, Samuel C Jr

Correction of MYBPC3 c.772G>A Splice-Site Mutation by Base Editing Ameliorates Hypertrophic Cardiomyopathy in Humanized Mice

通过碱基编辑纠正MYBPC3 c.772G>A剪接位点突变可改善人源化小鼠的肥厚型心肌病

Zhang, Yimeng; Jiao, Shouye; Yang, Guan; Wang, Jian; Yang, Xiao; Li, Zhenhua

NPM3 functions as a lactyltransferase to promote necroptosis in male diabetic cardiomyopathy mice models via FASN transcription modulation

NPM3作为一种乳酰转移酶,通过调控FASN转录,促进雄性糖尿病心肌病小鼠模型中的坏死性凋亡。

Xu, Hongjiao; Jiang, Xinyu; Wang, Fangrui; Meng, Fufen; Liu, Yue; Huang, Jiechun; Li, Jinbao; Zhu, Minmin

Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM Registry

左心房储血应变预测肥厚型心肌病患者的心房颤动:来自 NHLBI HCM 注册研究的启示

Beyhoff, Niklas; Agnel, Owen P; Fenski, Maximilian; Botrous, Christina; Tan, Yi Jie Gifford; Smillie, Robert W; Ashkir, Zakariye; Finnigan, Lucy E M; Dolman, Sarahfaye F; Kolm, Paul; Weintraub, William S; Kwong, Raymond Y; Jerosch-Herold, Michael; Desai, Milind Y; Ho, Carolyn Y; Desvigne-Nickens, Patrice; DiMarco, John P; Casadei, Barbara; Watkins, Hugh C; Kramer, Christopher M; Neubauer, Stefan; Raman, Betty

HSPA12A impairs lipophagy to exaggerate septic cardiomyopathy by promoting MTOR's competition against LC3-II in binding with PNPLA2.

HSPA12A 会损害脂质自噬,从而加剧脓毒症性心肌病,其机制是通过促进 MTOR 与 LC3-II 竞争与 PNPLA2 结合。

Li Yunfan, Liu Shijiang, Min Xinxu, Cheng Hao, Zhang Xiaojin, Liu Jiali, Xia Yudong, Wang Xiaohui, Jiang Guohua, Hao Ruijinling, Li Chuanfu, Liu Li, Kong Qiuyue, Ding Zhengnian

Redox-Responsive Tellurium-Bridged Covalent Organic Frameworks/PEG Composites for Targeted Therapy of Diabetic Cardiomyopathy

用于糖尿病心肌病靶向治疗的氧化还原响应型碲桥共价有机框架/聚乙二醇复合材料

Xue, Jing; Zhuang, Jialu; Fan, Taotao; Tang, Songtao; Wang, Junjun; Liu, Xiaohui; Liu, Jian; Shi, Jin; Li, Jiaji; Li, Wanjun; Hu, Danyou; Zhang, Xiaoqian; Wang, Hua; Zhang, Guiyang

Physical Activity and Cardiovascular Outcomes in Phenotype-Negative Cardiomyopathy Variant Carriers

表型阴性心肌病变异携带者的身体活动与心血管结局

Ajufo, Ezimamaka; Kany, Shinwan; Jurgens, Sean J; Churchill, Timothy W; Guseh, J Sawalla; Aragam, Krishna G; Nauffal, Victor; Pirruccello, James P; Choi, Seung Hoan; Lakdawala, Neal K; Ho, Carolyn Y; Ellinor, Patrick T; Khurshid, Shaan